Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group?-Reference-Cited by-同舟云学术

Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group?

Published:2020-02-09 Issue:6 Volume:75 Page:1327-1336
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Kleine‐Tebbe Jörg¹^ORCID,Zuberbier Torsten²³^ORCID,Werfel Thomas⁴^ORCID,Krüll Matthias⁵^ORCID,Wagenmann Martin⁶^ORCID,Johansen Niels⁷^ORCID,Adler Würtzen Peter⁷^ORCID,Wolf Hendrik⁸^ORCID,Mücke Victoria⁸^ORCID,Wüstenberg Eike⁸⁹^ORCID,Biedermann Tilo¹⁰¹¹^ORCID

Affiliation:

1. Allergy & Asthma Center Westend Berlin Germany

2. Charité Universitätsmedizin Berlin Freie Universität Berlin Humboldt Universität zu Berlin Berlin Germany

3. Department of Dermatology and Allergy Berlin Institute of Health Berlin Germany

4. Division of Immunodermatology and Allergy Research Department of Dermatology and Allergy Hannover Medical School Hannover Germany

5. Institut für Allergie und Asthmaforschung Berlin (IAAB) GbR Berlin Germany

6. Department of Otorhinolaryngology & Head/Neck Surgery University Hospital Duesseldorf Heinrich Heine University Duesseldorf Germany

7. Global Research ALK‐Abellò A/S Hørsholm Denmark

8. Medical Department ALK‐Abelló Arzneimittel GmbH Hamburg Germany

9. Department of Otorhinolaryngology University of Dresden Dresden Germany

10. Department of Dermatology and Allergology Technical University of Munich Munich Germany

11. Clinical Unit Allergology Helmholtz Zentrum München German Research Center for Environmental Health GmbH Neuherberg Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14130

Reference50 articles.

1. Analysis of the Antibody Responses Induced by Subcutaneous Injection Immunotherapy with Birch and Fagales Pollen Extracts Adsorbed onto Aluminum Hydroxide

2. Allergenic pollen and pollen allergy in Europe

3. Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy

4. Committee for Medicinal Products for Human Use (CHMP): Guideline on Allergen products: Production and quality issues. EMEA/CHMP/BWP/304831/2007 London 2008.

5. Committee for Medicinal Products for Human Use (CHMP): Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. CHMP/EWP/18504/2006 London 2008.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real‐life;Clinical and Translational Allergy;2024-07

2. Trimeric Bet v 1-specific nanobodies cause strong suppression of IgE binding;Frontiers in Immunology;2024-05-03

3. Structural and Immunological Features of PR-10 Allergens: Focusing on the Major Alder Pollen Allergen Aln g 1;International Journal of Molecular Sciences;2024-05-02

4. SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials;Acta Paediatrica;2024-03-26

5. mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens;2024-02-29